SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 212 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $24,657 | +502.3% | 852 | +654.0% | 0.00% | – |
Q1 2023 | $4,094 | -92.3% | 113 | -92.5% | 0.00% | – |
Q4 2022 | $53,469 | -94.9% | 1,499 | -95.1% | 0.00% | -100.0% |
Q3 2022 | $1,039,000 | -41.4% | 30,696 | -49.9% | 0.00% | -33.3% |
Q2 2022 | $1,772,000 | +4119.0% | 61,272 | +4657.1% | 0.00% | – |
Q1 2022 | $42,000 | -42.5% | 1,288 | -48.2% | 0.00% | – |
Q4 2021 | $73,000 | -37.1% | 2,488 | -42.7% | 0.00% | – |
Q3 2021 | $116,000 | +182.9% | 4,339 | +173.9% | 0.00% | – |
Q1 2021 | $41,000 | +115.8% | 1,584 | +112.6% | 0.00% | – |
Q4 2020 | $19,000 | -26.9% | 745 | -41.0% | 0.00% | – |
Q3 2020 | $26,000 | -90.5% | 1,262 | -89.1% | 0.00% | -100.0% |
Q2 2020 | $274,000 | -33.5% | 11,550 | -49.6% | 0.00% | -66.7% |
Q1 2020 | $412,000 | -78.6% | 22,926 | -71.8% | 0.00% | -76.9% |
Q4 2019 | $1,927,000 | +573.8% | 81,260 | +680.0% | 0.01% | +550.0% |
Q3 2019 | $286,000 | +65.3% | 10,418 | +99.8% | 0.00% | 0.0% |
Q2 2019 | $173,000 | -9.9% | 5,214 | -4.7% | 0.00% | 0.0% |
Q1 2019 | $192,000 | -64.6% | 5,474 | -66.5% | 0.00% | -60.0% |
Q4 2018 | $543,000 | +393.6% | 16,357 | +646.2% | 0.01% | +400.0% |
Q3 2018 | $110,000 | +511.1% | 2,192 | +380.7% | 0.00% | – |
Q4 2017 | $18,000 | -50.0% | 456 | -49.8% | 0.00% | – |
Q3 2017 | $36,000 | -81.0% | 908 | -87.8% | 0.00% | -100.0% |
Q4 2016 | $189,000 | +38.0% | 7,471 | -16.9% | 0.00% | 0.0% |
Q1 2016 | $137,000 | -86.1% | 8,986 | -90.0% | 0.00% | -86.7% |
Q2 2014 | $984,000 | -66.6% | 89,882 | -72.7% | 0.02% | -70.0% |
Q1 2014 | $2,948,000 | +96.1% | 329,801 | +65.5% | 0.05% | +117.4% |
Q4 2013 | $1,503,000 | – | 199,273 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 297,500 | $17,478,000 | 3.94% |
ASHFORD CAPITAL MANAGEMENT INC | 1,124,405 | $36,341,000 | 3.91% |
ARMISTICE CAPITAL, LLC | 3,100,000 | $100,192,000 | 1.94% |
S&T BANK/PA | 316,326 | $10,224,000 | 1.54% |
Bruce & Co., Inc. | 222,105 | $7,178,000 | 1.47% |
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 379,875 | $12,278,000 | 1.36% |
RICE HALL JAMES & ASSOCIATES, LLC | 854,949 | $27,632,000 | 1.10% |
Soleus Capital Management, L.P. | 251,000 | $8,112,000 | 1.05% |
Parkman Healthcare Partners LLC | 108,954 | $3,521,000 | 1.03% |
Aristotle Capital Boston, LLC | 1,258,067 | $40,661,000 | 1.03% |